Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance

Author(s):  Greeson Nicole MH, Mixon William, Allan W Chris

Issue:  Sep/Oct 2020 - Volume 24, Number 5
View All Articles in Issue

Abstract:  In the U.S., compounding pharmacies are regulated primarily by state boards of pharmacy, which often collaborate with federal agencies such as the Drug Enforcement Administration or the Department of Health and Human Services. Other organizations, such as the U.S. Food and Drug Administration, the Occupat ional Safety and Health Administration, the Environmental Protection Agency, and state departments of agriculture or labor may also have jurisdiction over compounding pharmacies and their employees. In addition, compounding pharmacies are subject to the requirements of Section 503A of the Federal Food, Drug, and Cosmetic Act. Complying with requirements for training and competency and documenting adherence to various agency regulations may seem daunting, but guidance in doing so is available from independent organizations such as the United States Pharmacopeial Convention, Inc., and the Pharmacy Compounding Accreditation Board. In this second article in a series on safety standards in pharmaceutical compounding, we discuss the roles of several of those influential federal organizations and the benefits that guidance from independent agencies provides for compounding pharmacists. Questions of interest to pharmacists who seek to comply with established agency safety standards are also answered.

Related Keywords: Nicole M.H. Greeson, MS, CIH, William Mixon, RPh, MS, FIACP, FACA, W. Chris Allan, MPA, government agencies, state agencies, pharmacy regulation, state boards of pharmacy, drug safety standards, US Food and Drug Administration, FDA, National Institute for Occupational Safety and Health, NIOSH, Occupational Safety and Health Administration, OSHA, Environmental Protection Agency, EPA, United States Pharmacopeial Convention, Inc., USP, Pharmacy Compounding Accreditation Board, PCAB, chemical inventory list, personal protective equipment, PPE, hazardous chemicals

Related Categories: ENVIRONMENTAL , LEGAL, PROFESSIONAL ISSUES, INFORMATION RESOURCES

Printer-Friendly Version




Download in electronic PDF format for $35

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance Greeson Nicole MH, Mixon William, Allan W Chris Sep/Oct 2020 371-379 Buy
Safety Standards in Pharmaceutical Compounding, Part 1: The Occupational Safety and Health Administration Greeson Nicole MH, Mixon William, Allan W Chris Jul/Aug 2020 270-276 Buy
Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 1 Greeson Nicole MH, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R Sep/Oct 2019 387-391 Buy
Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 2 Greeson Nicole MH, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R Nov/Dec 2019 467-471 Buy
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr Sep/Oct 2017 356 Buy
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies Yoch Doug Mar/Apr 2017 95-102 Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr Jul/Aug 2016 351 View Sample
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Miller David G Jul/Aug 2015 303-305 Buy
Applying Quality of Design Concepts to Pharmacy Compounding Timko Robert J Nov/Dec 2015 453-463 Buy
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Allen Loyd V Jr Nov/Dec 2015 487-488 Buy